Investor
The company plans to use the funding to further build out its product capabilities and deepen relationships with health plans and third-party administrators.
The company will use the funds to enhance its AI platform, expand clinical and operational use cases, and scale its market reach.
The funding will help the company scale its AI-powered, in-network virtual psychiatry platform, which employs more than 800 full-time psychiatrists.
The doctor quality analytics company's total funding to date is around $200 million.
New York-based Somethings will use the funds to scale its mobile app that connects teens and young adults with trained peer mentors.
The California-based company will use the funds to expand its healthcare advocate network and platform, partnerships with payers and providers and for clinical research.
The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain barrier to help treat neurodegenerative diseases.
The company has filed to list its Class A shares as it looks to scale its AI- and blockchain-enabled telehealth platform after U.S. expansion and private financing.
The round brings the AI-enabled text-to-speech company's total funding to $781 million.
The company will use the funding for research and development, to launch new agentic AI tools across multiple modalities, and to scale its engineering, product and growth teams.